Oct 30 (Reuters) - Appili Therapeutics Inc APLI.TO :
* APPILI THERAPEUTICS INC - SIGNED A COLLABORATION,
DEVELOPMENT
AND SUPPLY AGREEMENT WITH DR. REDDY'S LABORATORIES AND GLOBAL
RESPONSE AID
* APPILI - AGREEMENTS TO ACCELERATE WORLDWIDE DEVELOPMENT,
COMMERCIALIZATION OF AVIGAN TABLETS FOR POTENTIAL TREATMENT AND
PREVENTION OF COVID-19
* APPILI THERAPEUTICS INC - DR. REDDY'S AND GRA WILL
CONTINUE TO
BE RESPONSIBLE FOR RESEARCH AND DEVELOPMENT, COMMERCIALIZATION,
OF AVIGAN
* APPILI - WILL BE RESPONSIBLE FOR US & CANADIAN CLINICAL
TRIALS
CONDUCTED & WILL RECEIVE PROFIT SHARE ON ALL US AND CANADIAN
SALES FOR A SPECIFIED TERM
Source text for Eikon: ID:nBw5X7bGTa
Further company coverage: APLI.TO
((Reuters.briefs@thomsonreuters.com;))